DeLancey JOL. Structural support of the urethra as it relates to stress urinary incontinence: The hammock hypothesis. Am J Obstet Gynecol. 1994;170(6):1713–23. https://doi.org/10.1016/s0002-9378(94)70346-9.

Article  CAS  PubMed  Google Scholar 

Mcguire EJ, Lytton B. Pubovaginal sling procedure for stress incontinence. J Urol. 1978;119(1):82–4. https://doi.org/10.1016/s0022-5347(17)57390-5.

Article  CAS  PubMed  Google Scholar 

Luber KM. The definition, prevalence, and risk factors for stress urinary incontinence. Rev Urol. 2004;6(3):3–9.

Google Scholar 

••Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, et al. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline. Journal of Urology. 2012;188(6S):2455–63. DOI: https://doi.org/10.1016/j.juro.2012.09.079. Evidence-based guideline statements from the American Urological Association (AUA) and Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) that provide a framework for diagnosis, overall management, and various treatment options for non-neurogenic overactive bladder.

Hartmann KE, McPheeters ML, Biller DH, Ward RM, McKoy JN, Jerome RN, et al. Treatment of overactive bladder in women. Evid Rep Technol Assess. 2009;187:1–120.

Google Scholar 

••Kobashi KC, Albo ME, Dmochowski RR, Ginsberg DA, Goldman HB, Gomelsky A, et al. Surgical Treatment of Female Stress Urinary Incontinence: AUA/SUFU Guideline. Journal of Urology. 2017;198(4):875–83. DOI: https://doi.org/10.1016/j.juro.2017.06.061. Evidence-based guideline statements from the AUA and SUFU that focuses on surgical options for treatment of SUI along with current data associated with each treatment. Evaluation, indications, and patient counseling is also discussed.

Hussain SM, Bray R. Urethral bulking agents for female stress urinary incontinence. Neurourol Urodyn. 2019;38(3):887–92. https://doi.org/10.1002/nau.23924.

Article  CAS  PubMed  Google Scholar 

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49. https://doi.org/10.1016/s0090-4295(02)02243-4.

Article  PubMed  Google Scholar 

Kerr LA. Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile. Rev Urol. 2005;7(1):S3-s11.

PubMed  PubMed Central  Google Scholar 

Zheng Y, Rovner E. Update on urethral bulking for stress urinary incontinence in women. Curr Urol Rep. 2022;23(10):203–9. https://doi.org/10.1007/s11934-022-01099-5.

Article  PubMed  Google Scholar 

Kirchin V, Page T, Keegan PE, Atiemo KO, Cody JD, McClinton S, et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev. 2017;7(7):cd003881. https://doi.org/10.1002/14651858.CD003881.pub4.

Article  PubMed  Google Scholar 

Ghoniem G, Boctor N. Update on urethral bulking agents for female stress urinary incontinence due to intrinsic sphincter deficiency. J Urol Res. 2014;1(2):1009.

Google Scholar 

Chapple C, Dmochowski R. Particulate versus non-particulate bulking agents in the treatment of stress urinary incontinence. Res Rep Urol. 2019;11:299–310. https://doi.org/10.2147/RRU.S220216.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoe V, Haller B, Yao HH, O’Connell HE. Urethral bulking agents for the treatment of stress urinary incontinence in women: a systematic review. Neurourol Urodyn. 2021;40(6):1349–88. https://doi.org/10.1002/nau.24696.

Article  PubMed  Google Scholar 

Ford AA, Rogerson L, Cody JD, Aluko P, Ogah JA. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017;7(7):cd006375. https://doi.org/10.1002/14651858.CD006375.pub4.

Article  PubMed  Google Scholar 

Nilsson CG, Palva K, Aarnio R, Morcos E, Falconer C. Seventeen years’ follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J. 2013;24(8):1265–9. https://doi.org/10.1007/s00192-013-2090-2.

Article  CAS  PubMed  Google Scholar 

•Richter HE, Albo ME, Zyczynski HM, Kenton K, Norton PA, Sirls LT, et al. Retropubic versus Transobturator Midurethral Slings for Stress Incontinence. New England Journal of Medicine. 2010;362(22):2066–76. https://doi.org/10.1056/NEJMoa0912658. Multicenter, randomized equivalence trial that compared treatment success at 12 months between retropubic versus transobturator MUS in women with stress urinary incontinence. Prior to this trial, there was limited data that compared different types of slings.

Kenton K, Stoddard AM, Zyczynski H, Albo M, Rickey L, Norton P, et al. 5-year longitudinal followup after retropubic and transobturator mid urethral slings. J Urol. 2015;193(1):203–10. https://doi.org/10.1016/j.juro.2014.08.089.

Article  PubMed  Google Scholar 

Daneshgari F, Kong W, Swartz M. Complications of mid urethral slings: important outcomes for future clinical trials. J Urol. 2008;180(5):1890–7. https://doi.org/10.1016/j.juro.2008.07.029.

Article  PubMed  Google Scholar 

Delorme E. Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women. Prog Urol. 2001;11(6):1306–13.

CAS  PubMed  Google Scholar 

Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction, Mesh Midurethral Slings for Stress Urinary Incontinence. 2019. https://sufuorg.com/docs/mus/sufu-mus-position-statementx.aspx.

Kwon J, Kim Y, Kim DY. Second-line surgical management after midurethral sling failure. Int Neurourol J. 2021;25(2):111–8. https://doi.org/10.5213/inj.2040278.139.

Article  PubMed  PubMed Central  Google Scholar 

•Albo ME, Richter HE, Brubaker L, Norton P, Kraus SR, Zimmern PE, et al. Burch Colposuspension versus Fascial Sling to Reduce Urinary Stress Incontinence. New England Journal of Medicine. 2007;356(21):2143–55. DOI: https://doi.org/10.1056/NEJMoa070416. Multicenter, randomized clinical trial that compared treatment success at 24 months in women with SUI who underwent the autologous rectus fascia PVS versus Burch colposuspension procedure. Prior to this trial, there were few randomized control trials comparing surgical procedures for SUI.

Nazemi TM, Kobashi KC. Complications of grafts used in female pelvic floor reconstruction: Mesh erosion and extrusion. Indian J Urol. 2007;23:153–60.

Article  PubMed  PubMed Central  Google Scholar 

Chaikin DC, Rosenthal J, Blaivas JG. Pubovaginal fascial sling for all types of stress urinary incontinence: long-term analysis. J Urol. 1998;160:1312–6.

Article  CAS  PubMed  Google Scholar 

Ostergard DR. Primary slings for everyone with genuine stress incontinence? The argument against. Int Urogynecol J PelvicFloor Dysfunct. 1997;8:321–2.

Article  CAS  Google Scholar 

Peng M, Sussman RD, Escobar C, Palmerola R, Pape DM, Smilen SS, et al. Rectus fascia versus fascia lata for autologous fascial pubovaginal sling: a single-center comparison of perioperative and functional outcomes. Urogynecology. 2020;26(8):493–7. https://doi.org/10.1097/SPV.0000000000000761.

Article  Google Scholar 

Athanasopoulos A, Gyftopoulos K, McGuire EJ. Efficacy and preoperative prognostic factors of autologous fascia rectus sling for treatment of female stress urinary incontinence. Urology. 2011;78(5):1034–8. https://doi.org/10.1016/j.urology.2011.05.069.

Article  PubMed  Google Scholar 

Morgan TO Jr, Westney OL, McGuire EJ. Pubovaginal sling: 4-year outcome analysis and quality of life assessment. J Urol. 2000;163(6):1845–8. https://doi.org/10.1016/s0022-5347(05)67557-x.

Article  PubMed  Google Scholar 

Lapitan MCM, Cody JD, Mashayekhi A. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2017;7(7):cd002912. https://doi.org/10.1002/14651858.CD002912.pub7.

Article  PubMed  Google Scholar 

Dean N, Ellis G, Herbison GP, Wilson D, Mashayekhi A. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2017. https://doi.org/10.1002/14651858.CD002239.pub3.

Article  PubMed  PubMed Central  Google Scholar 

Galloway NT, Davies N, Stephenson TP. The complications of colposuspension. Br J Urol. 1987;60:122–4.

Article  CAS  PubMed  Google Scholar 

Demirci F, Yucel O, Eren S, Alkan A, Demirci E, Yildirim U. Long-term results of Burch colposuspension. Gynecol Obstet Invest. 2001;51(4):243–7.

Article  CAS  PubMed  Google Scholar 

Nambiar A, Cody JD, Jeffery ST, Aluko P. Single-incision sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2017;7(7):cd008709. https://doi.org/10.1002/14651858.CD008709.pub3.

Article  PubMed  Google Scholar 

Lane GI, Barboglio-Romo P, Crescenze I, Raza D, Clemens JQ, Dahm P, Gupta P. 2020 Vaginal lasers for treating stress urinary incontinence in women. Cochrane Database Syst Rev. 2020;6:CD013643. https://doi.org/10.1002/14651858.CD013643.

Article  Google Scholar 

Lin KL, Chou SH, Long CY. Effect of Er:YAG laser for women with stress urinary incontinence. Biomed Res Int. 2019;2019:7915813. https://doi.org/10.1155/2019/7915813.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin YH, Chiang BJ, Liao CH. Mechanism of action of botulinum toxin a in treatment of functional urological disorders. Toxins (Basel). 2020. https://doi.org/10.3390/toxins12020129.

Article  PubMed  Google Scholar 

Rovner E. Chapter 6: practical aspects of administration of onabotulinumtoxinA. Neurourol Urodyn. 2014. https://doi.org/10.1002/nau.22637.

Article  PubMed  Google Scholar 

•Visco AG, Brubaker L, Richter HE, Nygaard I, Paraiso MF, Menefee SA, et al. Anticholinergic versus botulinum toxin A comparison trial for the treatment of bothersome urge urinary incontinence: ABC trial. Contemp Clin Trials. 2012;33(1):184–96. https://doi.org/10.1016/j.cct.2011.09.019. Randomized, double-blind, control trial that compared UUI episodes over 6 months, along with overall tolerability and cost effectiveness between anticholinergic therapy versus intra-detrusor botulinum toxin injection. An innovative trial that challenged traditional clinical beliefs and treatment approaches for moderate to severe UUI.

Gupta P, Ehlert MJ, Sirls LT, Peters KM. Percutaneous tibial nerve stimulation and sacral neuromodulation: an update. Curr Urol Rep. 2015;16(2):4. https://doi.org/10.1007/s11934-014-0479-1.

Article  PubMed  Google Scholar 

Cooperberg MR, Stoller ML. Percutaneous neuromodulation. Urol Clin North Am. 2005;32(1):71–8. https://doi.org/10.1016/j.ucl.2004.09.007.

Article  PubMed  Google Scholar 

Sanford MT, Suskind AM. Neuromodulation in neurogenic bladder. Transl Androl Urol. 2016;5(1):117–26. https://doi.org/10.3978/j.issn.2223-4683.2015.12.01.

Article  PubMed  PubMed Central  Google Scholar 

•Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Sham Efficacy in the Treatment of Overactive Bladder Syndrome: Results From the SUmiT Trial. Journal of Urology. 2010;183(4):1438–43. https://doi.org/10.1016/j.juro.2009.12.036. Multicenter, double-blind randomized control trial that compared the efficacy at 12 weeks of PTNS versus sham therapy. This trial was the first randomized controlled neuromodulation study, providing level I evidence and corroborating existing published data regarding the safety and efficacy of PTNS.

Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the step study. J Urol. 2013;189(6):2194–201. https://doi.org/10.1016/j.juro.2012.11.175.

Article  PubMed